Fibulin-2: a novel biomarker for differentiating grade II from grade I meningiomas

There is an unmet need for the identification of biomarkers to aid in the diagnosis, clinical management, prognosis and follow-up of meningiomas. There is currently no consensus on the optimum management of WHO grade II meningiomas. In this study, we identified the calcium binding extracellular matr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sofela, Agbolahan A. (VerfasserIn) , Hilton, David A. (VerfasserIn) , Ammoun, Sylwia (VerfasserIn) , Baiz, Daniele (VerfasserIn) , Adams, Claire L. (VerfasserIn) , Ercolano, Emanuela (VerfasserIn) , Jenkinson, Michael D. (VerfasserIn) , Kurian, Kathreena M. (VerfasserIn) , Teo, Mario (VerfasserIn) , Whitfield, Peter C. (VerfasserIn) , Sahm, Felix (VerfasserIn) , Hanemann, C. Oliver (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 8 January 2021
In: International journal of molecular sciences
Year: 2021, Jahrgang: 22, Heft: 2, Pages: 1-13
ISSN:1422-0067
DOI:10.3390/ijms22020560
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/ijms22020560
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/1422-0067/22/2/560
Volltext
Verfasserangaben:Agbolahan A. Sofela, David A. Hilton, Sylwia Ammoun, Daniele Baiz, Claire L. Adams, Emanuela Ercolano, Michael D. Jenkinson, Kathreena M. Kurian, Mario Teo, Peter C. Whitfield, Felix Sahm and C. Oliver Hanemann

MARC

LEADER 00000caa a2200000 c 4500
001 1750734400
003 DE-627
005 20220819131006.0
007 cr uuu---uuuuu
008 210308s2021 xx |||||o 00| ||eng c
024 7 |a 10.3390/ijms22020560  |2 doi 
035 |a (DE-627)1750734400 
035 |a (DE-599)KXP1750734400 
035 |a (OCoLC)1341398132 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sofela, Agbolahan A.  |e VerfasserIn  |0 (DE-588)1228790701  |0 (DE-627)1750735520  |4 aut 
245 1 0 |a Fibulin-2  |b a novel biomarker for differentiating grade II from grade I meningiomas  |c Agbolahan A. Sofela, David A. Hilton, Sylwia Ammoun, Daniele Baiz, Claire L. Adams, Emanuela Ercolano, Michael D. Jenkinson, Kathreena M. Kurian, Mario Teo, Peter C. Whitfield, Felix Sahm and C. Oliver Hanemann 
246 3 3 |a Fibulin- two 
264 1 |c 8 January 2021 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 08.03.2021 
520 |a There is an unmet need for the identification of biomarkers to aid in the diagnosis, clinical management, prognosis and follow-up of meningiomas. There is currently no consensus on the optimum management of WHO grade II meningiomas. In this study, we identified the calcium binding extracellular matrix glycoprotein, Fibulin-2, via mass-spectrometry-based proteomics, assessed its expression in grade I and II meningiomas and explored its potential as a grade II biomarker. A total of 87 grade I and 91 grade II different meningioma cells, tissue and plasma samples were used for the various experimental techniques employed to assess Fibulin-2 expression. The tumours were reviewed and classified according to the 2016 edition of the Classification of the Tumours of the central nervous system (CNS). Mass spectrometry proteomic analysis identified Fibulin-2 as a differentially expressed protein between grade I and II meningioma cell cultures. Fibulin-2 levels were further evaluated in meningioma cells using Western blotting and Real-time Quantitative Polymerase Chain Reaction (RT-qPCR); in meningioma tissues via immunohistochemistry and RT-qPCR; and in plasma via Enzyme-Linked Immunosorbent Assay (ELISA). Proteomic analyses (p < 0.05), Western blotting (p < 0.05) and RT-qPCR (p < 0.01) confirmed significantly higher Fibulin-2 (FBLN2) expression levels in grade II meningiomas compared to grade I. Fibulin-2 blood plasma levels were also significantly higher in grade II meningioma patients compared to grade I patients. This study suggests that elevated Fibulin-2 might be a novel grade II meningioma biomarker, when differentiating them from the grade I tumours. The trend of Fibulin-2 expression observed in plasma may serve as a useful non-invasive biomarker. 
650 4 |a atypical 
650 4 |a benign 
650 4 |a biomarker 
650 4 |a meningioma 
650 4 |a plasma 
700 1 |a Hilton, David A.  |e VerfasserIn  |4 aut 
700 1 |a Ammoun, Sylwia  |e VerfasserIn  |4 aut 
700 1 |a Baiz, Daniele  |e VerfasserIn  |4 aut 
700 1 |a Adams, Claire L.  |e VerfasserIn  |4 aut 
700 1 |a Ercolano, Emanuela  |e VerfasserIn  |4 aut 
700 1 |a Jenkinson, Michael D.  |e VerfasserIn  |4 aut 
700 1 |a Kurian, Kathreena M.  |e VerfasserIn  |4 aut 
700 1 |a Teo, Mario  |e VerfasserIn  |4 aut 
700 1 |a Whitfield, Peter C.  |e VerfasserIn  |4 aut 
700 1 |a Sahm, Felix  |d 1984-  |e VerfasserIn  |0 (DE-588)1022852132  |0 (DE-627)717318478  |0 (DE-576)366075020  |4 aut 
700 1 |a Hanemann, C. Oliver  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t International journal of molecular sciences  |d Basel : Molecular Diversity Preservation International, 2000  |g 22(2021), 2, Artikel-ID 560, Seite 1-13  |h Online-Ressource  |w (DE-627)316340715  |w (DE-600)2019364-6  |w (DE-576)281194653  |x 1422-0067  |7 nnas  |a Fibulin-2 a novel biomarker for differentiating grade II from grade I meningiomas 
773 1 8 |g volume:22  |g year:2021  |g number:2  |g elocationid:560  |g pages:1-13  |g extent:13  |a Fibulin-2 a novel biomarker for differentiating grade II from grade I meningiomas 
856 4 0 |u https://doi.org/10.3390/ijms22020560  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/1422-0067/22/2/560  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210308 
993 |a Article 
994 |a 2021 
998 |g 1022852132  |a Sahm, Felix  |m 1022852132:Sahm, Felix  |d 910000  |d 912000  |d 50000  |e 910000PS1022852132  |e 912000PS1022852132  |e 50000PS1022852132  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 11 
999 |a KXP-PPN1750734400  |e 3882632011 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1750734400","physDesc":[{"extent":"13 S."}],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"8 January 2021"}],"relHost":[{"note":["Gesehen am 17.09.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"title":[{"title":"International journal of molecular sciences","title_sort":"International journal of molecular sciences"}],"origin":[{"publisher":"Molecular Diversity Preservation International","dateIssuedKey":"2000","dateIssuedDisp":"2000-","publisherPlace":"Basel"}],"disp":"Fibulin-2 a novel biomarker for differentiating grade II from grade I meningiomasInternational journal of molecular sciences","physDesc":[{"extent":"Online-Ressource"}],"recId":"316340715","part":{"pages":"1-13","extent":"13","text":"22(2021), 2, Artikel-ID 560, Seite 1-13","issue":"2","year":"2021","volume":"22"},"id":{"zdb":["2019364-6"],"issn":["1422-0067","1661-6596"],"eki":["316340715"]},"pubHistory":["1.2000 -"],"titleAlt":[{"title":"IJMS"}]}],"person":[{"display":"Sofela, Agbolahan A.","given":"Agbolahan A.","role":"aut","family":"Sofela"},{"family":"Hilton","given":"David A.","role":"aut","display":"Hilton, David A."},{"display":"Ammoun, Sylwia","given":"Sylwia","role":"aut","family":"Ammoun"},{"family":"Baiz","role":"aut","given":"Daniele","display":"Baiz, Daniele"},{"family":"Adams","given":"Claire L.","role":"aut","display":"Adams, Claire L."},{"family":"Ercolano","role":"aut","given":"Emanuela","display":"Ercolano, Emanuela"},{"family":"Jenkinson","given":"Michael D.","role":"aut","display":"Jenkinson, Michael D."},{"role":"aut","given":"Kathreena M.","family":"Kurian","display":"Kurian, Kathreena M."},{"display":"Teo, Mario","role":"aut","given":"Mario","family":"Teo"},{"display":"Whitfield, Peter C.","role":"aut","given":"Peter C.","family":"Whitfield"},{"given":"Felix","role":"aut","family":"Sahm","display":"Sahm, Felix"},{"given":"C. Oliver","role":"aut","family":"Hanemann","display":"Hanemann, C. Oliver"}],"title":[{"subtitle":"a novel biomarker for differentiating grade II from grade I meningiomas","title":"Fibulin-2","title_sort":"Fibulin-2"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 08.03.2021"],"name":{"displayForm":["Agbolahan A. Sofela, David A. Hilton, Sylwia Ammoun, Daniele Baiz, Claire L. Adams, Emanuela Ercolano, Michael D. Jenkinson, Kathreena M. Kurian, Mario Teo, Peter C. Whitfield, Felix Sahm and C. Oliver Hanemann"]},"titleAlt":[{"title":"Fibulin- two"}],"id":{"doi":["10.3390/ijms22020560"],"eki":["1750734400"]}} 
SRT |a SOFELAAGBOFIBULIN28202